FTII
FutureTech II Acquisition Corp.
Key Financials
Net Income
$-746953
↓ 125.7%
Operating Income
$-314906
N/A
Cash & Equivalents
$262756.00
↑ 5155.1%
Total Assets
$28.1M
↓ 55.2%
Total Liabilities
$27.9M
↑ 400.6%
Shareholders' Equity
$-8854673.00
↓ 166.2%
Operating Cash Flow
$-1925582.00
↓ 9.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 4/1/2026 | View on SEC |
| 8-K | 3/10/2026 | View on SEC |
| 8-K | 2/19/2026 | View on SEC |
| 8-K | 1/16/2026 | View on SEC |
| RW | 11/26/2025 | View on SEC |
| NT 10-Q | 11/14/2025 | View on SEC |
| 8-K | 11/12/2025 | View on SEC |
| 10-Q | 8/22/2025 | View on SEC |
| 8-K | 8/18/2025 | View on SEC |
| 8-K | 8/18/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FTII |
| Company Name | FutureTech II Acquisition Corp. |
| CIK | 1889450 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 9143164805 |